Waldenström's macroglobulinemia risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Common risk factors in the development of waldenström's macroglobulinemia are [[monoclonal gammopathy of undetermined significance]], [[hereditary]], [[hepatitis C]], and immune disorders.<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref>
Common risk factors in the development of Waldenström macroglobulinemia are [[monoclonal gammopathy of undetermined significance]], [[hereditary|heredity]], [[hepatitis C]], and autoimmune disorders.<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref>


==Risk Factors==
==Risk Factors==
Following are the common risk factors associated with waldenström's macroglobulinemia:
Common risk factors in the development of Waldenström macroglobulinemia include:<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref>
* [[Monoclonal gammopathy of undetermined significance]] (MGUS)
** Pre-existing [[monoclonal gammopathy of undetermined significance]] is the most common risk factor for the development of Waldenström's macroglobulinemia.


'''Monoclonal gammopathy of undetermined significance''': Pre-existing [[monoclonal gammopathy of undetermined significance]] is the most common risk factor for the development of waldenström's macroglobulinemia.<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref>
* Heredity
** Patients with Waldenström's macroglobulinemia usually have a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of [[lymphoma]] or [[leukemia]].


'''Heredity''': Patients with waldenström's macroglobulinemia has a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of [[lymphoma]] or [[leukemia]].
* Hepatitis C
** Patients with chronic [[hepatitis C]] infection are more likely to develop Waldenström macroglobulinemia than general population.


'''Hepatitis C''': Patients with chronic [[hepatitis C]] infection are more likely to develop waldenström's macroglobulinemia than general population.
* Autoimmune Diseases
 
** Certain autoimmune diseases, such as [[sjögren syndrome]], increase the risk of developing Waldenström macroglobulinemia.
'''Immune Diseases:''' Autoimmune diseases, such as [[sjögren syndrome]], increase the risk of developing waldenström's macroglobulinemia.


==References==
==References==
Line 22: Line 25:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Blood]]
[[Category:Blood]]
[[Category:Hematology]]
[[Category:Hematology]]

Revision as of 20:06, 30 October 2018

Waldenström's macroglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Waldenström's macroglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Bone Marrow Aspiration and Biopsy

Electrophoresis and Immunofixation

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Waldenström's macroglobulinemia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Waldenström's macroglobulinemia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Waldenström's macroglobulinemia risk factors

CDC on Waldenström's macroglobulinemia risk factors

Waldenström's macroglobulinemia risk factors in the news

Blogs on Waldenström's macroglobulinemia risk factors

Directions to Hospitals Treating Waldenström's macroglobulinemia

Risk calculators and risk factors for Waldenström's macroglobulinemia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]

Overview

Common risk factors in the development of Waldenström macroglobulinemia are monoclonal gammopathy of undetermined significance, heredity, hepatitis C, and autoimmune disorders.[1]

Risk Factors

Common risk factors in the development of Waldenström macroglobulinemia include:[1]

  • Heredity
    • Patients with Waldenström's macroglobulinemia usually have a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of lymphoma or leukemia.
  • Hepatitis C
    • Patients with chronic hepatitis C infection are more likely to develop Waldenström macroglobulinemia than general population.
  • Autoimmune Diseases
    • Certain autoimmune diseases, such as sjögren syndrome, increase the risk of developing Waldenström macroglobulinemia.

References

  1. 1.0 1.1 Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015

Template:WH Template:WS